What is NAD IV Therapy
A staggering 73% of physicians surveyed have been forced to reduce or completely stop a patients GLP-1 therapy due to cost and insurance coverage issues, representing countless patients who started a life-changing treatment only to have it pulled away for reasons outside of their or their doctors control
PMID: 74 KolbH
These include: Neurological symptoms : tingling or numbness in hands and feet (peripheral neuropathy), difficulty walking or balance problems, memory difficulties, or mood changes including depression Haematological signs : persistent fatigue, weakness, pale or jaundiced skin, or shortness of breath Glossitis : a sore, red, smooth tongue Cognitive symptoms : difficulty concentrating, confusion, or "brain fog" Seek urgent medical attention if you experience rapidly worsening neurological symptoms, significant difficulty walking, severe paraesthesia, or marked cognitive decline, as these may require immediate assessment
The molecular weight of GHK-Cu sits between 340 and 404 g/mol depending on the salt form, making it a small molecule that distributes efficiently through tissue after injection
